Citations for
1MEN2A, MEN2B, RET
Multiple endocrine neoplasia type 2.
Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP.
Best Pract Res Clin Endocrinol Metab 24(3):371-87.PMID: 20833330 2010
2RET, MEN2B
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.
Cranston AN, Carniti C, Oakhill K, Radzio-Andzelm E, Stone EA, McCallion AS, Hodgson S, Clarke S, Mondellini P, Leyland J, Pierotti MA, Whittaker J, Taylor SS, Bongarzone I, Ponder BA.
Cancer Res 66(20):10179-87. 2006
3RET, MEN2A, MEN2B
Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
Cancer 94(2):323-30. 2002
4MEN2B, RET
Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.
Miyauchi A, et al.
Jpn J Cancer Res 90(1):1-5. 1999
5RET, MEN2B, MTC1
Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.
Iwashita T, et al.
Oncogene 18(26):3919-22 1999
6MEN2A, MEN2B, MTC1, RET
Prevalence and parental origin of De novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma.
Schuffenecker I, et al.
Am J Hum Genet 60 : 233-237. 1997
7HSCR1, MEN2A, MEN2B, RET
Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease.
Eng C, et al.
Hum Mutat 9 : 97-109. 1997
8MEN2B, RET
Germline mutation of RET codon 883 in two cases of de novo MEN 2B.
Smith DP, Houghton C, Ponder BA.
Oncogene 15(10):1213-7. 1997
9MEN2A, MEN2B, MTC1, RET
Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC : two novel mutations and one De novo mutation for MEN2A.
Landsvater RM, et al.
Hum Genet 97 : 11-14. 1996
10RET, MEN2A, MEN2B
A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B.
Cosma MP, et al.
Biochem J 314 : 397-400. 1996
11RET, MEN2A, MEN2B
Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Pausova Z, et al.
J Clin Endocrinol Metab 81 : 2711-2718. 1996
12MEN2A, MEN2B, RET
Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers.
Landsvater RM, et al.
Cancer Res 56 : 4853-4855. 1996
13RET, MEN2A, MEN2B, MTC1
Genotype-phenotype correlation in multiple endocrine neoplasia type 2 : report of the international RET mutation consortium.
Mulligan LM, et al.
J Int Med 238 : 343-346. 1995
14MEN2B, RET
Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families.
Rossel M, et al.
Hum Genet 95 : 403-406. 1995
15MEN2A, MEN2B, MTC1, RET
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
Mulligan LM, et al.
Nat Genet 6 : 70-74. 1994
16RET, MTC1, MEN2B
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RMW, et al.
Nature 367 : 375-376. 1994
17MEN2B, RET
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
Eng C, et al.
Hum Mol Genet 3 : 237-241. 1994
18RET, MEN2B
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
Carlson KM, et al.
Proc Natl Acad Sci U S A 91 : 1579-1583. 1994
19MEN2A, MEN2B, MTC1
Somatic and MEN 2A De novo mutations identified in the RET proto-oncogene by screening of sporadic MTC's.
Zedenius J, et al.
Hum Mol Genet 3 : 1259-1262. 1994
20MEN2A, MEN2B, RET
Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
Maruyama S, et al.
Jpn J Cancer Res 85 : 879-882. 1994
21MEN2B
Parent-of-origin effects in multiple endocrine neoplasia type 2B.
Carlson KM, et al.
Am J Hum Genet 55 : 1076-1082. 1994
22MEN2A, MEN2B
Isolation of region-specific cosmids by hybridization with microdissection clones from human chromosome 10q11.1-q21.1.
Karakawa K, et al.
Genomics 17 : 449-455. 1993
23MEN2A, MEN2B
Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF, et al.
Cancer Res 52 : 770-774. 1992
24MEN2A, MEN2B, MTC1
A cluster of CpG islands in 10q11.2: implications for cloning the MEN2A,MEN2B and MTC1 gene(s).
Brooks-Wilson AR, et al.
(HGM11) Cytogenet Cell Genet 58 : 1947. 1991
25MEN2B
Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.
Norum RA, et al.
Genomics 8 : 313-317. 1990
26MEN2B, MTC1
Linkage of MEN-IIb to chromosome 10 and linkage studies in familial medullary thyroid carcinoma.
Lairmore TC, et al.
Am J Hum Genet 47 : A187. 1990
27MEN2A, MEN2B
Genetic events in tumorigenesis in multiple endocrine neoplasia type 2.
Ponder BAJ, et al.
Cancer Cells 7 : 219-221. 1989
28MEN2B
Linkage between MEN2B and chromosome 10 markers linked to MEN2A.
Jackson CE, et al.
Am J Hum Genet 43 : A147. 1988